Crestline Management, LP 13F Holdings · Q2 2026
Crestline Management, LP reported 3 securities worth $53.48M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: DNLI (91.90%), SANA (4.93%), EGHT (3.17%). Among its top 25 positions this quarter: 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | DNLI | DENALI THERAPEUTICS INC | $49.1M | 91.90% | 1.9M | Trimmed |
| 2 | SANA | SANA BIOTECHNOLOGY INC | $2.6M | 4.93% | 755,736 | Hold |
| 3 | EGHT | 8X8 INC NEW | $1.7M | 3.17% | 990,850 | Hold |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR